Status:
COMPLETED
The Prevalence of Gastro-oesophageal Reflux in Chronic Lung Disease
Lead Sponsor:
Bayside Health
Collaborating Sponsors:
University of Melbourne
Conditions:
Chronic Obstructive Pulmonary Disease
Bronchiectasis
Eligibility:
All Genders
20-80 years
Brief Summary
Gastric reflux into the oesophagus may further lung damage in respiratory disease. The proportion of adults with chronic lung disease and gastric reflux is unknown. Adults with this disease regularly ...
Detailed Description
Research plan: Fifty-four subjects will be recruited from the Department of AIRMED outpatient clinics at the Alfred Hospital, Melbourne. Subjects will be considered eligible if they have a diagnosis ...
Eligibility Criteria
Inclusion
- Diagnosis of Chronic obstructive pulmonary disease according to GOLD classification
- Diagnosis of Bronchiectasis
- Medically stable, without hospital admission in month prior to study
Exclusion
- diagnosis of asthma, cystic fibrosis, interstitial lung disease
- known hiatus hernia, oesophageal varices, obstructive sleep apnoea
- medically unstable for exercise
Key Trial Info
Start Date :
July 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00697177
Start Date
July 1 2005
End Date
June 1 2009
Last Update
February 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alfred Hospital
Melbourne, Victoria, Australia, 3004